Osteosarcoma Clinical Trials

Active, Not Recruiting

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

NCT06416085

Conditions: Advanced Cancer, Endocrine Cancer, Endocrine Gland Neoplasms, +28 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

NCT04616248

Conditions: Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Basal Cell Carcinoma, +44 more
Locations: Los Angeles General Medical Center Los Angeles, California, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

NCT03213704

Conditions: Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +83 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 124 locations

View Trial Details

Active, Not Recruiting

Methionine PET/CT Studies In Patients With Cancer

NCT00840047

Conditions: Brain Stem Glioma, Brain Tumors and/or Solid Tumors Including, Craniopharyngioma, +36 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, Not Recruiting

Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

NCT03698994

Conditions: Advanced Malignant Solid Neoplasm, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, +83 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 107 locations

View Trial Details

Active, Not Recruiting

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

NCT04320888

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, Female Urogenital Diseases, +85 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

View all 174 locations

View Trial Details

Active, Not Recruiting

Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma

NCT02502786

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +5 more
Locations: Children's Hospital of Los Angeles (Data Collection Only) Los Angeles, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

MD ANDERSON CANCER CENTER (Data Collection Only) Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma

NCT02243605

Conditions: Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Neoplasms, +15 more
Locations: Institut Bergonie Cancer Center Bordeaux, France

Centre Georges-Francois Leclerc Dijon, France

Centre Oscar Lambert Lille, France

Centre Leon Berard Lyon, France

View Trial Details

Active, Not Recruiting

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

NCT03449108

Conditions: Adnexal Diseases, Bone Diseases, Bone Neoplasms, +49 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients

NCT03643133

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +4 more
Locations: CHU Amiens-Picardie - Service d'oncologie hématologie pédiatrique Amiens, France

CHU d'Angers - Service d'oncologie pédiatrique Angers, France

Institut Bergonié - Service d'oncologie médicale Bordeaux, France

CHU de Caen - Service d'oncologie hématologie pédiatrique Caen, France

View all 31 locations

View Trial Details

Osteosarcoma

Osteosarcoma trial results

Related conditions